LS
CELG

Livforsakringsbolaget Skandia’s Celgene Corp CELG Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-23,510
Closed -$2.33M – 672
2019
Q3 		$2.33M Hold
23,510
– – 0.28% 99
2019
Q2 		$2.17M Sell
23,510
-21,300
-48% -$2.02M 0.27% 102
2019
Q1 		$4.23M Hold
44,810
– – 0.56% 43
2018
Q4 		$2.87M Buy
44,810
+400
+0.9% +$29.5K 0.43% 66
2018
Q3 		$3.97M Sell
44,410
-15,100
-25% -$1.33M 0.47% 55
2018
Q2 		$4.73M Buy
59,510
+1,600
+3% +$133K 0.43% 56
2018
Q1 		$5.17M Hold
57,910
– – 0.5% 47
2017
Q4 		$6.04M Sell
57,910
-600
-1% -$67.7K 0.58% 39
2017
Q3 		$8.53M Sell
58,510
-1,928
-3% -$263K 0.76% 26
2017
Q2 		$7.85M Hold
60,438
– – 0.72% 29
2017
Q1 		$7.52M Sell
60,438
-23,400
-28% -$2.8M 0.7% 31
2016
Q4 		$9.71K Sell
83,838
-50,061
-37% -$5.58M 0.49% 40
2016
Q3 		$1.75M Buy
133,899
+20,116
+18% +$2.18M 0.09% 312
2016
Q2 		$11.2M Buy
113,783
+14,300
+14% +$1.48M 0.5% 42
2016
Q1 		$9.96M Hold
99,483
– – 0.47% 46
2015
Q4 		$11.9M Buy
99,483
+6,300
+7% +$729K 0.56% 41
2015
Q3 		$10.1M Hold
93,183
– – 0.53% 39
2015
Q2 		$10.8M Buy
93,183
+2,473
+3% +$283K 0.53% 39
2015
Q1 		$10.5M Sell
90,710
-4,100
-4% -$490K 0.51% 40
2014
Q4 		$10.6M Sell
94,810
-27,300
-22% -$2.88M 0.5% 39
2014
Q3 		$11.6M Buy
122,110
+55,155
+82% +$4.98M 0.44% 44
2014
Q2 		$5.75M Sell
66,955
-66,955
-50% -$5.09M 0.21% 116
2014
Q1 		$9.35M Buy
133,910
+119,710
+843% +$9.48M 0.35% 61
2013
Q4 		$1.2M Hold
14,200
– – 0.78% 42
2013
Q3 		$1.09M Buy
14,200
+2,800
+25% +$196K 0.76% 44
2013
Q2 		$667K Buy
+11,400
New +$686K 0.48% 75

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Livforsakringsbolaget Skandia's CELG Position: Q4 2019 in Review

Livforsakringsbolaget Skandia sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 23,510 shares — an estimated $2.33M sold.

Livforsakringsbolaget Skandia first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $11.9M in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Livforsakringsbolaget Skandia reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Livforsakringsbolaget Skandia sold 23,510 Celgene Corp shares in Q4 2019, an estimated $2.33M.
  • Livforsakringsbolaget Skandia first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Livforsakringsbolaget Skandia's Celgene Corp position peaked at $11.9M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Livforsakringsbolaget Skandia's 13F filing for Q4 2019, filed 28 Jan 2020.